{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/16571-768#drug","name":"Darifenacin","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"16571-768"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"ANDA206743"},{"@type":"PropertyValue","propertyID":"UNII","value":"CR02EYQ8GV"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"e2aa9544-0136-463d-a73b-1a299534446a"}],"activeIngredient":"DARIFENACIN HYDROBROMIDE","administrationRoute":["ORAL"],"dosageForm":"TABLET, FILM COATED, EXTENDED RELEASE","manufacturer":{"@type":"Organization","name":"Rising Pharma Holdings, Inc."},"drugClass":[],"isAvailableGenerically":true,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/ANDA206743","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e2aa9544-0136-463d-a73b-1a299534446a","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=16571-768"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-02T03:52:14.317Z"}}